Royal Bank of Canada
BOLD

Royal Bank of Canada’s Boundless Bio BOLD Stock Holding History

Royal Bank of Canada’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-97
Closed – – 7605
2025
Q2 		$0 Sell
97
-765
-89% -$1.02K ﹤0.01% 7417
2025
Q1 		$1K Sell
862
-1,954
-69% -$4.05K ﹤0.01% 6736
2024
Q4 		$8K Buy
2,816
+1,844
+190% +$5.37K ﹤0.01% 6422
2024
Q3 		$3K Buy
972
+379
+64% +$1.37K ﹤0.01% 6620
2024
Q2 		$2K Sell
593
-24,040
-98% -$230K ﹤0.01% 6763
2024
Q1 		$351K Buy
+24,633
New +$351K ﹤0.01% 4220

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada's BOLD Position: Q3 2025 in Review

Royal Bank of Canada sold out of Boundless Bio (BOLD) in Q3 2025, closing a stake of 97 shares.

Royal Bank of Canada first reported a position in BOLD in Q1 2024 and held it in 6 quarters. The position peaked at $351K in Q1 2024. 35 funds tracked by Wall St. Rank hold BOLD as of Q3 2025.

  • Royal Bank of Canada reported no remaining Boundless Bio position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 97 Boundless Bio shares in Q3 2025.
  • Royal Bank of Canada first reported a position in Boundless Bio in Q1 2024 and held it in 6 quarters.
  • Royal Bank of Canada's Boundless Bio position peaked at $351K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.